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Dyspnea Scores May be a Better Predictor of Hospital Admissions than FEV1 for
Patients with Acute Asthma Exacerbations
John Schneider1, Kazuko Matsuda MD PhD2, Stacey House MD PhD1, Ian Ferguson1, Kristen Aubuchon1, Lawrence Lewis MD1
1Division of Emergency Medicine, Washington University in St. Louis, St. Louis, Missouri; 2Medicinova, Inc., San Diego, California
BACKGROUND
•The NAEPP Expert Panel Report 3 suggests that repeated lung function measures
(FEV1 or PEF) 1 hour after initiation of treatment is the strongest single predictor of
hospitalization.
•It is also stated that signs and symptoms scores may improve the ability to predict
subsequent hospitalization
OBJECTIVES
•To compare repeated FEV1 to a repeated Modified Borg Dyspnea Scale (DS) as a
predictor of subsequent hospitalization.

RESULTS
•44 patients were included for analysis.
•Rho is negative for FEV1 (higher FEV1 correlates to lower rate of hospitalization) and
positive for DS (higher DS correlates to higher rate of hospitalization).
•At each time point, except for baseline, DS was more highly correlated to hospitalization
than was FEV1 (table).
• Delta DS ≤ 1.5 showed 73.3% admission rate vs. 27.5 admission rate for delta
DS>1.5 (p=0.0089)
• Delta FEV1< 10% showed 51.6% admission rate compared to 23.1% admission rate
for delta FEV1>10%. (p=0.1048)
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METHODS

CONCLUSION

•Interim, sub-analysis of an interventional, randomized, double blind, placebo-controlled
trial of an intravenous beta agonist performed in an academic, urban-based ,adult ED.
•Inclusion criteria:

• Dyspnea score at 1, 2 and 3 hours was more highly correlated with hospital admission
than was FEV1 . Delta DS < 1.5 as well as delta FEV1 < 10% was associated with a
significant increase in admission rate.

TABLE:

• Adult subjects with acute exacerbation of asthma (and no Hx of COPD)
• FEV1< 50% predicted 30 minutes following initiation of “standard care” (including a
minimum of 5 mg nebulized albuterol; 0.5 mg nebulized ipratropium; and 50 mg
corticosteroid) were eligible.
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• In this set of subjects with moderate to severe asthma exacerbation, a standardized
subjective tool appears somewhat superior to FEV1 for predicting subsequent
hospitalization.
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DISCUSSION
• This data highlights the potential limitations of the FEV1 as a prognostic indicator for
hospital admission.
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• FEV1 may be effort and technique dependent

•FEV1 was measured using a bedside Nspire spirometer,
•DS was calculated using a Modified Borg Dyspnea score (see figure).
•Delta FEV1 is defined as Hr 3 FEV1 - Baseline FEV1. Delta DS is defined as Baseline
DS - Hr 3 DS.

Sig.

P value

(2-tailed)

•Spearman’s rho was used to measure correlation between FEV1, DS (at baseline, hr 1,
hr 2, and hr 3), and delta FEV1 and delta DS and subsequent hospitalization.
• A 1.5 point improvement in delta DS was compared to a 10% improvement in delta
FEV1 for predicting subsequent hospitalization using Fisher’s exact test.

.

• This may be due to a number of factors:

• FEV1 may be abnormal at baseline in these patients, thus low FEV1 may not
correlate with acute exacerbation
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• Continued dyspnea scores may be more important in the decision making process for
emergency physicians than FEV1

